59 related articles for article (PubMed ID: 22087699)
1. HRAS mutation mosaicism causing urothelial cancer and epidermal nevus.
Hafner C; Toll A; Real FX
N Engl J Med; 2011 Nov; 365(20):1940-2. PubMed ID: 22087699
[No Abstract] [Full Text] [Related]
2. Schimmelpenning-Feuerstein-Mims syndrome induced by HRAS Gly12Ser somatic mosaic mutation: Case report and literature review.
Ono H; Yamaguchi R; Arai M; Togi S; Ura H; Niida Y; Shimizu A
J Dermatol; 2023 Sep; 50(9):1213-1215. PubMed ID: 37170693
[TBL] [Abstract][Full Text] [Related]
3. Maintenance of the bladder cancer precursor urothelial hyperplasia requires FOXA1 and persistent expression of oncogenic HRAS.
Yee CH; Zheng Z; Shuman L; Yamashita H; Warrick JI; Wu XR; Raman JD; DeGraff DJ
Sci Rep; 2019 Jan; 9(1):270. PubMed ID: 30670749
[TBL] [Abstract][Full Text] [Related]
4. Woolly hair nevus type 1 caused by somatic HRAS p.A59T mutation.
March-Rodriguez A; Escolà H; Lobato-Berezo A; Curto-Barredo L; Pujol RM
Int J Dermatol; 2024 Jan; 63(1):135-136. PubMed ID: 38013513
[No Abstract] [Full Text] [Related]
5. Melorheostosis: Exome sequencing of an associated dermatosis implicates postzygotic mosaicism of mutated KRAS.
Whyte MP; Griffith M; Trani L; Mumm S; Gottesman GS; McAlister WH; Krysiak K; Lesurf R; Skidmore ZL; Campbell KM; Rosman IS; Bayliss S; Bijanki VN; Nenninger A; Van Tine BA; Griffith OL; Mardis ER
Bone; 2017 Aug; 101():145-155. PubMed ID: 28434888
[TBL] [Abstract][Full Text] [Related]
6. HRAS mosaicism in linear palmoplantar keratoderma.
Clabbers JMK; Roemen GMJM; Rajan N; Shah A; Woo P; Arefi M; Vreeburg M; Steijlen PM; Gostyński A; van Geel M
J Eur Acad Dermatol Venereol; 2024 May; 38(5):e382-e384. PubMed ID: 37909292
[No Abstract] [Full Text] [Related]
7. Widespread keratinocytic epidermal nevus with an associated chylous pericardial effusion.
Rowe G; Snyder KM; Treat JR
Pediatr Dermatol; 2023; 40(5):962-963. PubMed ID: 37232077
[TBL] [Abstract][Full Text] [Related]
8. Phacomatosis pigmentokeratotica is caused by a postzygotic HRAS mutation in a multipotent progenitor cell.
Groesser L; Herschberger E; Sagrera A; Shwayder T; Flux K; Ehmann L; Wollenberg A; Torrelo A; Bagazgoitia L; Diaz-Ley B; Tinschert S; Oschlies I; Singer S; Mickler M; Toll A; Landthaler M; Real FX; Hafner C
J Invest Dermatol; 2013 Aug; 133(8):1998-2003. PubMed ID: 23337891
[TBL] [Abstract][Full Text] [Related]
9. Postzygotic HRAS and KRAS mutations cause nevus sebaceous and Schimmelpenning syndrome.
Groesser L; Herschberger E; Ruetten A; Ruivenkamp C; Lopriore E; Zutt M; Langmann T; Singer S; Klingseisen L; Schneider-Brachert W; Toll A; Real FX; Landthaler M; Hafner C
Nat Genet; 2012 Jun; 44(7):783-7. PubMed ID: 22683711
[TBL] [Abstract][Full Text] [Related]
10. Case Report: Sequential postzygotic
Zuntini R; Cattani C; Pedace L; Miele E; Caraffi SG; Gardini S; Ficarelli E; Pizzi S; Radio FC; Barone A; Piana S; Bertolini P; Corradi D; Marinelli M; Longo C; Motolese A; Zuffardi O; Tartaglia M; Garavelli L
Front Genet; 2023; 14():1231434. PubMed ID: 37636262
[TBL] [Abstract][Full Text] [Related]
11. Current Treatment of Juvenile Myelomonocytic Leukemia.
Mayerhofer C; Niemeyer CM; Flotho C
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300250
[TBL] [Abstract][Full Text] [Related]
12. Cutaneous Squamous Cell Carcinoma in the Age of Immunotherapy.
Ishitsuka Y; Hanaoka Y; Tanemura A; Fujimoto M
Cancers (Basel); 2021 Mar; 13(5):. PubMed ID: 33800195
[TBL] [Abstract][Full Text] [Related]
13. The duality of human oncoproteins: drivers of cancer and congenital disorders.
Castel P; Rauen KA; McCormick F
Nat Rev Cancer; 2020 Jul; 20(7):383-397. PubMed ID: 32341551
[TBL] [Abstract][Full Text] [Related]
14. DNA methylation-regulated QPCT promotes sunitinib resistance by increasing HRAS stability in renal cell carcinoma.
Zhao T; Bao Y; Gan X; Wang J; Chen Q; Dai Z; Liu B; Wang A; Sun S; Yang F; Wang L
Theranostics; 2019; 9(21):6175-6190. PubMed ID: 31534544
[No Abstract] [Full Text] [Related]
15. A case of woolly hair nevus, multiple linear pigmentation, and epidermal nevi with somatic HRAS p.G12S mutation.
Nishihara K; Tohyama M; Kubo A
Pediatr Dermatol; 2019 May; 36(3):368-371. PubMed ID: 30864170
[TBL] [Abstract][Full Text] [Related]
16. Germline mutations in ABL1 cause an autosomal dominant syndrome characterized by congenital heart defects and skeletal malformations.
Wang X; Charng WL; Chen CA; Rosenfeld JA; Al Shamsi A; Al-Gazali L; McGuire M; Mew NA; Arnold GL; Qu C; Ding Y; Muzny DM; Gibbs RA; Eng CM; Walkiewicz M; Xia F; Plon SE; Lupski JR; Schaaf CP; Yang Y
Nat Genet; 2017 Apr; 49(4):613-617. PubMed ID: 28288113
[TBL] [Abstract][Full Text] [Related]
17. New insights into the generation and role of de novo mutations in health and disease.
Acuna-Hidalgo R; Veltman JA; Hoischen A
Genome Biol; 2016 Nov; 17(1):241. PubMed ID: 27894357
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Carbon Dioxide Laser in the Treatment of Epidermal Nevi.
Bhat YJ; Hassan I; Sajad P; Yaseen A; Mubashir S; Akhter S; Wani R
J Cutan Aesthet Surg; 2016; 9(3):183-187. PubMed ID: 27761089
[TBL] [Abstract][Full Text] [Related]
19. Genetic causes of cancer predisposition in children and adolescents.
Saletta F; Dalla Pozza L; Byrne JA
Transl Pediatr; 2015 Apr; 4(2):67-75. PubMed ID: 26835363
[TBL] [Abstract][Full Text] [Related]
20. Somatic mosaicism: on the road to cancer.
Fernández LC; Torres M; Real FX
Nat Rev Cancer; 2016 Jan; 16(1):43-55. PubMed ID: 26678315
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
